Conference Overview
The NCCN 2026 Annual Conference focuses on the practical management of patients living with or at risk for cancer, updates of NCCN Guidelines®, and new treatments, therapies, and trends, and their application in patient care.
The conference also provides a venue for education around best practices for cancer care delivery with the new Operational Excellence in Cancer Care Program.
This conference is approved for AMA PRA Category 1 Credit™, ABIM, ABPath, ABS, and ABMS MOC for physicians, and is also certified for credit for physician associates, nurses, pharmacists, case managers, and other oncology professionals.
FRIDAY, MARCH 27, 2026
7:30 – 8:30 AM
Registration, Breakfast Exhibits, and General Poster Session
7:50 – 8:20 AM
Non-CE Product Theater
Evolving Strategies for Adults with Previously Treated Locally Advanced or Metastatic EGFRm NSCLC
Presented by Daiichi Sankyo and AstraZeneca
8:30 – 9:45 AM
Welcoming Remarks
Crystal S. Denlinger, MD
CEO, National Comprehensive Cancer Network
PLENARY SESSION
The New Face of Cancer: Supporting Younger Adults Across the Care Continuum
MODERATOR
Christopher H. Lieu, MD
University of Colorado Cancer Center
PANELIST
Anjali Albanese, MSW, LSW, OSW-C
Fox Chase Cancer Center
PANELIST
Leidy L. Isenalumhe, MD, MS
Moffitt Cancer Center
PANELIST
Larissa Nekhlyudov, MD, MPH
Dana-Farber/Brigham and Women's Cancer Center
PANELIST
Stephanie Samolovitch, MSW
Young Adult Survivors United
9:45 – 10:05 AM
Break, Exhibits, and General Poster Session
Continue the Conversation: Cancer Care for Younger Adults
Not CE-certified. Available for in-person attendees only.
9:45 – 10:15 AM
Non-CE Product Theater
Summit Trial Results: Efficacy & Safety of Bezuclastinib in Nonadvanced Systemic Mastocytosis
Presented by Cogent Biosciences, Inc.
10:05 AM – 12:05 PM
GASTROINTESTINAL CANCERS
MODERATOR:
Saurin A. Chokshi, MD
The University of Tennessee Health Science Center
Advances in Early-Stage Colorectal Cancer Care: Integrating Emerging Evidence into Practice**
Jeffrey Meyerhardt, MD, MPH
Dana-Farber Cancer Institute
The Evolving Treatment Landscape for Gastric/ Esophageal/ EGJ Cancers**
Mary F. Mulcahy, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Novel Treatment Strategies for Management of Advanced Hepatocellular Carcinoma**
Adam M. Burgoyne, MD, PhD
UC San Diego Moores Cancer Center
Appendiceal Cancer Care: What Clinicians Need to Know**
Stacey A. Cohen, MD
Fred Hutchinson Cancer Center
12:05 – 1:20 PM
Lunch, Exhibits, and General Poster Session/Tour
12:05 – 12:25 PM
Continue the Conversation: Gastrointestinal Cancers
Not CE-certified. Available for in-person attendees only.
12:10 – 12:40 PM
Non-CE Product Theater
A Practice-Changing Advancement in the Treatment of Resectable Gastric/Gastroesophageal Junction Cancers
Presented by AstraZeneca
12:30 – 1:10 PM
Follow the Expert Guided Poster Tour
Not CE-certified. Available for in-person attendees only.
Saurin A. Chokshi, MD
The University of Tennessee Health Science Center
12:45 – 1:15 PM
Non-CE Product Theater
First-Line Treatment Option for Lower-Risk MDS: COMMANDS Trial Overview
Presented by Bristol Myers Squibb
1:20 – 2:50 PM
SKIN CANCERS
Practical Approaches to Advanced Melanoma Care**
Douglas B. Johnson, MD, MSCI
Vanderbilt-Ingram Cancer Center
Therapeutic Strategies for Non-Melanoma Skin Cancers**
Vincent T. Ma, MD
University of Wisconsin Carbone Cancer Center
Translating Emerging Therapies into Clinical Practice in Uveal Melanoma Care**
Arun D. Singh, MD
Cole Eye Institute and Cleveland Clinic Taussig Cancer Institute
2:50 – 3:10 PM
Break, Exhibits, and General Poster Session
Continue the Conversation: Skin Cancers
Not CE-certified. Available for in-person attendees only.
3:10 – 4:40 PM
HEMATOLOGIC MALIGNANCIES
MODERATOR:
Edwin P. Alyea III, MD
Duke Cancer Institute
The Evolving Role of Transplant in Newly Diagnosed TP53 Wild-Type Classical Mantle Cell Lymphoma
Paolo F. Caimi, MD
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Novel Approaches for Treating TP53-Mutated Classical Mantle Cell Lymphoma**
Ann S. LaCasce, MD, MMSc
Dana-Farber Cancer Institute
Relapsed/Refractory Multiple Myeloma: Evidence-Based Approaches to Therapy Selection and Sequencing**
Shaji K. Kumar, MD
Mayo Clinic Comprehensive Cancer Center
4:15 – 5:30 PM
Oral Presentations from Top Poster Presenters
Not CE-certified.
MODERATOR:
Matthew Robinson, PhD
Senior Director, Oncology Research Program
National Comprehensive Cancer Network
PRESENTER
Ali Ajrouch, MD
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
PRESENTER
Reem Dergham, MD
Roswell Park Comprehensive Cancer Center
PRESENTER
Ecem Kalemoglu, MD, PhD
Jersey City Medical Center
PRESENTER
Chiugo Okoye, MBBS
Northeast Georgia Medical Center Gainesville
PRESENTER
Sana Zeb, BA
Abramson Cancer Center at the University of Pennsylvania
4:40 – 5:00 PM
Continue the Conversation: Hematologic Malignancies
Not CE-certified. Available for in-person attendees only.
7:00 – 9:00 PM
Welcome Reception
6:30 – 9:15 PM
Kid’s Nite Out
Drop off your kids for their own night out while you attend the Welcome Reception. Children will be chaperoned by Kid's Nite Out and provided dinner, a movie screening, and group activities and games. Pre-register for this free offering during conference registration.
SATURDAY, MARCH 28, 2026
7:30 – 8:30 AM
Registration, Breakfast Exhibits, and General Poster Session
7:30 – 8:30 AM
Non-CE Product Theater
A New Treatment Approach for Cisplatin-Ineligible Patients with MIBC
Presented by Astellas Pharma US, Inc. and Pfizer Inc.
8:30 – 9:45 AM
Opening Remarks
Alyssa Schatz, DrPH, MSW
Vice President, Policy & Advocacy
National Comprehensive Cancer Network
PLENARY SESSION
Delivering Cancer Care Worldwide: Current Realities and Future Strategies
MODERATOR
Nadeem R. Abu-Rustum, MD
Memorial Sloan Kettering Cancer Center
PANELIST
Kunuz Abdella, MD, MSc
Federal Ministry of Health-Ethiopia
African Cancer Coalition (ACC) Secretariat
PANELIST
Anu K. Agrawal, MD
American Cancer Society
PANELIST
Kanan Alshammari, MBChB
Ministry of National Guard - Health Affairs
PANELIST
Carolyn Taylor
Global Focus on Cancer
9:45 – 10:05 AM
Break, Exhibits, and General Poster Session
9:45 – 10:05 AM
Continue the Conversation: Worldwide Cancer Care
Not CE-certified. Available for in-person attendees only.
9:45 – 10:15 AM
Non-CE Product Theater
Learn About an Alternative Treatment for R/R CLL/SLL
Presented by Eli Lilly and Company
10:05 AM – 12:05 PM
GENITOURINARY CANCERS
MODERATOR
Juskaran S. Chadha, DO, MBA
Moffitt Cancer Center
Selecting the Optimal Treatment Approach for Patients with Metastatic Prostate Cancer**
Sandy Srinivas, MD
Stanford Cancer Institute
Integrating New and Emerging Treatments into Bladder Cancer Care**
Thomas W. Flaig, MD
University of Colorado Cancer Center
Charles C. Peyton, MD
O'Neal Comprehensive Cancer Center at UAB
From Guidelines to Practice: Systemic Therapy Strategies in Advanced Renal Cell Carcinoma**
Naomi B. Haas, MD
Abramson Cancer Center at the University of Pennsylvania
12:05 – 1:20 PM
Lunch, Exhibits, and General Poster Session/Tour
12:05 – 12:25 PM
Continue the Conversation: Genitourinary Cancers
Not CE-certified. Available for in-person attendees only.
12:30 – 1:10 PM
Follow the Expert Guided Poster Tour
Not CE-certified. Available for in-person attendees only.
Michael J. Hall, MD, MS
Fox Chase Cancer Center
12:10 – 12:40 PM
Non-CE Product Theater
From Red Flags to Unmet Needs: The Patient Journey in AL Amyloidosis
Presented by Alexion, AstraZeneca Rare Disease
12:45 – 1:15 PM
Non-CE Product Theater
Navigating a New Era of First-Line HER2+ mBC Treatment
Presented by Daiichi Sankyo, Inc. and AstraZeneca
1:20 – 2:50 PM
GYNECOLOGIC CANCERS
MODERATOR
Nadeem R. Abu-Rustum, MD
Memorial Sloan Kettering Cancer Center
Integrating Brachytherapy and Emerging Systemic Therapies into Cervical Cancer Care**
Junzo P. Chino, MD
Duke Cancer Institute
Applying Molecular Advances in the Management of Endometrial Cancer**
Ritu Salani, MD, MBA
UCLA Jonsson Comprehensive Cancer Center
Evolving Ovarian Cancer Care: Surgical and Systemic Approaches**
Shitanshu Uppal, MBBS, MBA
University of Michigan Rogel Cancer Center
1:30 – 2:45 PM
Oral Presentations from the NCCN Foundation Young Investigator Awardees
Not CE-certified.
MODERATOR
Matthew Robinson, PhD
Senior Director, Oncology Research Program
National Comprehensive Cancer Network
PRESENTER
Zachary Burke, MD
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
PRESENTER
Calista Harbaugh, MD, MSc
University of Michigan Rogel Cancer Center
PRESENTER
Alexander Muir, PhD
The UChicago Medicine Comprehensive Cancer Center
PRESENTER
Andreas Rauschecker, MD, PhD
UCSF Helen Diller Family Comprehensive Cancer Center
PRESENTER
James W. Smithy, MD, MHS
Memorial Sloan Kettering Cancer Center
2:50 – 3:10 PM
Break, Exhibits, and General Poster Session
Continue the Conversation: Gynecologic Cancers
Not CE-certified. Available for in-person attendees only.
NCCN Overview: Clinical and Patient Resources
Presented by NCCN. Not CE-certified.
3:10 – 4:25 PM
Maximizing Benefit, Minimizing Risk: Managing Immune Checkpoint Inhibitor Toxicities**
Saurin A. Chokshi, MD
The University of Tennessee Health Science Center
Alvin Chandra, MD
UT Southwestern Simmons Comprehensive Cancer Center
Brittany Dulmage, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
4:30 – 5:15 PM
Harnessing Artificial Intelligence to Improve Oncology Care
MODERATOR
Penelope Fu, MD, MPH
City of Hope National Medical Center
PRESENTER
Travis Osterman, DO, MS
Vanderbilt-Ingram Cancer Center
5:15 – 5:30 PM
Continue the Conversation: Immunotherapy and AI
Not CE-certified. Available for in-person attendees only.
SUNDAY, MARCH 29, 2026
7:00 –7:30 AM
Registration and Breakfast
7:30 – 9:00 AM
Opening Remarks
Renuka V. Iyer, MD
Chief Medical Officer
National Comprehensive Cancer Network
Non-Small Cell Lung Cancer Case Review**
Lyudmila Bazhenova, MD
UC San Diego Moores Cancer Center
David E. Gerber, MD
UT Southwestern Simmons Comprehensive Cancer Center
Daniel Morgensztern, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
9:00 – 9:15 AM
Break
9:15 – 11:00 AM
Breast Cancer Case Review**
William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Meena S. Moran, MD
Yale Cancer Center/Smilow Cancer Hospital
Jessica S. Young, MD
Roswell Park Comprehensive Cancer Center
11:00 AM
Closing Remarks
Crystal S. Denlinger, MD
CEO, National Comprehensive Cancer Network
Agenda subject to change.
Additional speakers will be added once confirmed.
**: Indicates sessions that offer pharmacotherapeutic contact hours for nurses.
Non-CE Product Theaters: The information and views expressed in these presentations are solely that of the presenters and do not necessarily reflect the position and policies of NCCN. NCCN makes no warranties of any kind whatsoever regarding their content, use, or application and disclaims any responsibility for their application or use in any way.